Wei Du
- Pharmacology top 0.5%
- Molecular Biology top 2%
- Ginseng Biological Effects and Applications 23
- Ubiquitin and proteasome pathways 13
- Natural product bioactivities and synthesis 12
- Developmental Biology and Gene Regulation 11
- Epigenetics and DNA Methylation 10
- Cancer Research top 5%
- Cancer-related molecular mechanisms research 12
- Oncology top 2%
- Cancer-related Molecular Pathways 32
- Cell Biology top 2%
- Microtubule and mitosis dynamics 9
- Co-authors
- Nicholas J. DysonTong‐Chuan HeShijie XinChun‐Su YuanChong‐Zhi WangMolly Duman‐ScheelLi WengJennifer Pogoriler
- Journals
- Developmental Biology (7 papers)Phytotherapy Research (4 papers)Proceedings of the National Academy of Sciences (4 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Wei Du
121 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 148
- Pharmacology 487
- Molecular Biology 3.5k
- Cancer Research 630
- Oncology 1.0k
- Cell Biology 599
Countries citing papers authored by Wei Du
This map shows the geographic impact of Wei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Du more than expected).
Fields of papers citing papers by Wei Du
This network shows the impact of papers produced by Wei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Du. The network helps show where Wei Du may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2020 | 6 | |
| 7 | 2018 | 16 | |
| 8 | 2018 | 63 | |
| 9 | 2017 | 11 | |
| 10 | Roles of adiponectin in alleviating myocardial ischemia-reperfusion injury in rats with remote ischemic postconditioning | 2017 | 1 |
| 11 | 2016 | 8 | |
| 12 | 2016 | 7 | |
| 13 | 2015 | 8 | |
| 14 | 2014 | 1 | |
| 15 | 2008 | 60 | |
| 16 | 2008 | 39 | |
| 17 | 2008 | 11 | |
| 18 | 2007 | 38 | |
| 19 | 2007 | 21 | |
| 20 | Apoptosis of K562 cells induced by diisopropylphosphoryl leucyl-lysine methyl ester | 2003 | 1 |
About Wei Du
Wei Du is a scholar working on Cancer Research, Pharmacology, Oncology, Molecular Biology and Cell Biology, having authored 129 papers that have together received 4.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (32 papers), Ginseng Biological Effects and Applications (23 papers), Ubiquitin and proteasome pathways (13 papers), Natural product bioactivities and synthesis (12 papers), Cancer-related molecular mechanisms research (12 papers), Developmental Biology and Gene Regulation (11 papers), Epigenetics and DNA Methylation (10 papers) and Microtubule and mitosis dynamics (9 papers). The work is most often cited by research in Pharmacology (487 citations), Molecular Biology (3.5k citations), Cancer Research (630 citations), Oncology (1.0k citations) and Cell Biology (599 citations). Wei Du has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Nicholas J. Dyson, Tong‐Chuan He, Shijie Xin, Chun‐Su Yuan, Chong‐Zhi Wang, Molly Duman‐Scheel, Li Weng, Jennifer Pogoriler, Giovanni Bosco and Marc Vidal. Their work appears in journals such as Developmental Biology, Phytotherapy Research, Proceedings of the National Academy of Sciences, Cancer Letters and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.